https://pubmed.ncbi.nlm.nih.gov/33258451/ This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content U.S. flag An official website of the United States government Here's how you know Dot gov The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. Https The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. NIH NLM Logo Log in Show account info Close Account Logged in as: username * Dashboard * Publications * Account settings * Log out Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation pubmed logo Search: [ ] Search Advanced Clipboard User Guide Save Email Send to * Clipboard * My Bibliography * Collections * Citation manager Display options Display options Format [Abstract] Save citation to file Format: [Summary (text) ] Create file Cancel Email citation Subject: 1 selected item: 33258451 - PubMed To: [ ] Format: [Summary ] [ ] MeSH and other data Send email Cancel Add to Collections * ( ) Create a new collection * (*) Add to an existing collection Name your collection: [ ] Name must be less than 100 characters Choose a collection: [] Unable to load your collection due to an error Please try again Add Cancel Add to My Bibliography * ( ) My Bibliography Unable to load your delegates due to an error Please try again Add Cancel Your saved search Name of saved search: [ ] Search terms: [ ] Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons * (*) Yes * ( ) No Email: (change) Frequency: [Monthly] Which day? [The first Sunday ] Which day? [Sunday ] Report format: [Summary ] Send at most: [5 items ] [ ] Send even when there aren't any new results Optional text in email: [ ] Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: [ ] Number of items displayed: [15 ] Create RSS Cancel RSS Link [ ] Copy Full text links full text provider logo eLife Sciences Publications, Ltd Free PMC article Full text links Actions Cite Favorites Display options Display options Format [Abstract] Share * * * Permalink [https://pubmed.ncbi.]Copy Page navigation * Title & authors * Abstract * Conflict of interest statement * Figures * Similar articles * Cited by * References * Publication types * MeSH terms * Substances * Related information * Grant support * LinkOut - more resources [Title & authors ] Elife Actions * Search in PubMed * Search in NLM Catalog * Add to Search . 2020 Dec 1;9:e62048. doi: 10.7554/eLife.62048. Small molecule cognitive enhancer reverses age-related memory decline in mice Karen Krukowski^ 1 2 , Amber Nolan^ #^ 2 3 , Elma S Frias^ #^ 1 2 , Morgane Boone^ #^ 4 , Gonzalo Ureta^ 5 , Katherine Grue^ 1 2 , Maria-Serena Paladini^ 1 2 , Edward Elizarraras^ 1 2 , Luz Delgado^ 5 , Sebastian Bernales^ 5 , Peter Walter^ 4 6 , Susanna Rosi^ 1 2 7 8 9 Affiliations Expand Affiliations * ^1 Department of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States. * ^2 Brain and Spinal Injury Center, University of California at San Francisco, San Francisco, United States. * ^3 Department of Pathology, University of California at San Francisco, San Francisco, United States. * ^4 Biochemistry and Biophysics, University of California at San Francisco, San Francisco, United States. * ^5 Fundacion Ciencia & Vida, Santiago, Chile. * ^6 Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, United States. * ^7 Department of Neurological Surgery, University of California at San Francisco, San Francisco, United States. * ^8 Weill Institute for Neuroscience, University of California at San Francisco, San Francisco, United States. * ^9 Kavli Institute of Fundamental Neuroscience, University of California at San Francisco, San Francisco, United States. ^# Contributed equally. * PMID: 33258451 * PMCID: PMC7721440 * DOI: 10.7554/eLife.62048 Free PMC article Item in Clipboard Small molecule cognitive enhancer reverses age-related memory decline in mice Karen Krukowski et al. Elife. 2020. Free PMC article Show details Display options Display options Format [Abstract] Elife Actions * Search in PubMed * Search in NLM Catalog * Add to Search . 2020 Dec 1;9:e62048. doi: 10.7554/eLife.62048. Authors Karen Krukowski^ 1 2 , Amber Nolan^ #^ 2 3 , Elma S Frias^ #^ 1 2 , Morgane Boone^ #^ 4 , Gonzalo Ureta^ 5 , Katherine Grue^ 1 2 , Maria-Serena Paladini^ 1 2 , Edward Elizarraras^ 1 2 , Luz Delgado^ 5 , Sebastian Bernales^ 5 , Peter Walter^ 4 6 , Susanna Rosi^ 1 2 7 8 9 Affiliations * ^1 Department of Physical Therapy and Rehabilitation Science, University of California at San Francisco, San Francisco, United States. * ^2 Brain and Spinal Injury Center, University of California at San Francisco, San Francisco, United States. * ^3 Department of Pathology, University of California at San Francisco, San Francisco, United States. * ^4 Biochemistry and Biophysics, University of California at San Francisco, San Francisco, United States. * ^5 Fundacion Ciencia & Vida, Santiago, Chile. * ^6 Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, United States. * ^7 Department of Neurological Surgery, University of California at San Francisco, San Francisco, United States. * ^8 Weill Institute for Neuroscience, University of California at San Francisco, San Francisco, United States. * ^9 Kavli Institute of Fundamental Neuroscience, University of California at San Francisco, San Francisco, United States. ^# Contributed equally. * PMID: 33258451 * PMCID: PMC7721440 * DOI: 10.7554/eLife.62048 Item in Clipboard Full text links Cite Display options Display options Format [Abstract] Abstract With increased life expectancy, age-associated cognitive decline becomes a growing concern, even in the absence of recognizable neurodegenerative disease. The integrated stress response (ISR) is activated during aging and contributes to age-related brain phenotypes. We demonstrate that treatment with the drug-like small-molecule ISR inhibitor ISRIB reverses ISR activation in the brain, as indicated by decreased levels of activating transcription factor 4 (ATF4) and phosphorylated eukaryotic translation initiation factor eIF2. Furthermore, ISRIB treatment reverses spatial memory deficits and ameliorates working memory in old mice. At the cellular level in the hippocampus, ISR inhibition (i) rescues intrinsic neuronal electrophysiological properties, (ii) restores spine density and (iii) reduces immune profiles, specifically interferon and T cell-mediated responses. Thus, pharmacological interference with the ISR emerges as a promising intervention strategy for combating age-related cognitive decline in otherwise healthy individuals. Keywords: ISR; aging; immune dysfunction; memory; mouse; neuroscience. (c) 2020, Krukowski et al. Conflict of interest statement KK, AN, EF, MB, KG, MP, EE, SR No competing interests declared, GU, LD works at Fundacion Ciencia & Vida and receives partial funding from Praxis Biotech. SB is an employee of Praxis Biotech and Fundacion Ciencia & Vida, and receives partial funding from Praxis Biotech. PW is an inventor on US Patent 9708247 held by the Regents of the University of California that describes ISRIB and its analogs. Rights to the invention have been licensed by UCSF to Calico. PW is an equity owner and consultant for Praxis Biotech LLC. Figures Figure 1. Figure 1.. ISRIB resets the ISR in... Figure 1.. ISRIB resets the ISR in the brain of old mice. ( A )... Figure 1.. ISRIB resets the ISR in the brain of old mice. (A) Experimental dosing scheme: ISRIB treatment denoted by syringes (three injections). (B) ISRIB treatment reduced ATF4 protein levels chronically 18 days after ISRIB treatment was complete. One-way ANOVA (F = 18.8, p<0.001); with Tukey post-hoc analysis. (C) Modest age-induced increases in p-GCN2 when comparing young and old male mice. One-way ANOVA (F = 6.6, p<0.05); with Tukey post-hoc analysis. (D, E) Age and ISRIB administration did not impact p-PERK or p-PKR protein levels. Brain lysates of specific protein levels listed normalized to actin. Young n = 5, Old = 3, Old + ISRIB = 3. Individual animal values represented by dots; lines depict group mean +- SEM. *p<0.05; ***p<0.001. Figure 1--figure supplement 1. Figure 1--figure supplement 1.. ISRIB downregulates ATF4... Figure 1--figure supplement 1.. ISRIB downregulates ATF4 during administration. The impact of ISRIB on known... Figure 1--figure supplement 1.. ISRIB downregulates ATF4 during administration. The impact of ISRIB on known ISR activation pathways was investigated by western blot analysis of brain lysates after 3 ISRIB injections. ( A) Raw western blot data. Each lane represents an individual animal brain extract. (B) ISRIB treatment reduced ATF4 protein levels during drug administration. Old males (Chou et al., 2018) and females (Anderson et al., 1998): Old n = 10; Old + ISRIB n = 10. Student's t-test. *p<0.05. Individual animal values represented by dots; lines depict group mean +- SEM. Figure 1--figure supplement 2. Figure 1--figure supplement 2.. ISRIB down-regulates the... Figure 1--figure supplement 2.. ISRIB down-regulates the ISR in the brain of old mice. The... Figure 1--figure supplement 2.. ISRIB down-regulates the ISR in the brain of old mice. The impact of ISRIB on known ISR kinases and activation pathways was investigated by western blot analysis of brain lysates (raw western blot data) at day 20. (A) ATF4 (B) p-GCN2, p-PKR, p-PERK. Each lane represents an individual animal brain extract. Figure 2. Figure 2.. Inhibition of the ISR reverses... Figure 2.. Inhibition of the ISR reverses age-induced decline in spatial, working, and episodic memory. Figure 2.. Inhibition of the ISR reverses age-induced decline in spatial, working, and episodic memory. (A) Experimental Design: Old (~19 months) animals underwent behavioral analysis in a radial arm water maze (RAWM) and a delayed matching to place paradigm (DMP). ISRIB or vehicle administration (2.5 mg/kg intraperitoneal) occurred daily during the learning phase of RAWM denoted by syringes (days 0-2). (B) ISRIB treatment improved memory 1 week after administration in male rodents. One-way ANOVA (F = 4.8, p<0.05); with Tukey post-hoc analysis. Young n = 10; Old n = 23; Old + ISRIB n = 21. (C) Age-induced deficits in working and episodic learning and memory restored weeks after ISRIB administration. Animals performed the DMP from day 20 to day 23. Average of all trials per group for each day. Days 20, 21 = 4 trials/ day. Days 22,23 = 3 trials/day. Two-way repeated measures ANOVA reveals a significant difference between groups p<0.01 (denoted in figure legend) and time effect p<0.01. *p<0.05, **p<0.01. Old n = 18; Old + ISRIB n = 16. Individual animal scores represented by dots; lines depict group mean +- SEM. Figure 2--figure supplement 1. Figure 2--figure supplement 1.. ISR inhibitors relieve... Figure 2--figure supplement 1.. ISR inhibitors relieve age-induced deficits in spatial learning. RAWM was used... Figure 2--figure supplement 1.. ISR inhibitors relieve age-induced deficits in spatial learning. RAWM was used to measure age-induced deficits in spatial learning. Animals ran two blocks (three trials/block) on each learning day. (A) Old animals performed significantly worse that young animals. Two-way repeated measures ANOVA revealed a significant interaction (p<0.001). Bonferroni post-hoc to determine differences at various blocks. Old males n = 19, Young males n = 10. *p<0.05. (B) ISRIB or vehicle administration (2.5 mg/kg intraperitoneal) occurred days 0-2. Compared with the old group, ISRIB treated animals made significantly fewer errors over the course of learning. Two-way repeated measures ANOVA reveals a significant difference between groups p<0.05. Old males n = 19; Old + ISRIB males n = 15. (C) No differences were measured between young +/- ISRIB administration. Two-way repeated measures ANOVA revealed no significant differences. Young males n = 10; Young males + ISRIB n = 10 (D) Cmp-003 (5 mg/kg intraperitoneal) administration occurred days 0-2. Old mice that received Cmp-003 performed significantly better than old mice that received vehicle. Two-way repeated measures ANOVA revealed a significant group (p<0.01) and time effect (p<0.05). Old males n = 9, Old males + Cmp-003 n = 9. **p<0.01. Data are means +- SEM. Figure 2--figure supplement 2. Figure 2--figure supplement 2.. ISRIB reduces age-induced... Figure 2--figure supplement 2.. ISRIB reduces age-induced memory deficits in female mice. RAWM was used... Figure 2--figure supplement 2.. ISRIB reduces age-induced memory deficits in female mice. RAWM was used to measure age-induced deficits in learning and memory. ISRIB treatment improved memory 1 week after administration in female rodents. Student t-test. Old female n = 12; Old female + ISRIB n = 11. *p<0.05. Individual animal scores represented by dots, lines depict group mean and SEM. Figure 3. Figure 3.. ISRIB treatment alleviates age-associated changes... Figure 3.. ISRIB treatment alleviates age-associated changes in CA1 pyramidal neuron function and structure. (... Figure 3.. ISRIB treatment alleviates age-associated changes in CA1 pyramidal neuron function and structure. (A) Left: Image of pipette patched onto CA1 neuron in sagittal slice of hippocampus. Right: Representative traces from hippocampal CA1 pyramidal neurons from old animals treated with either vehicle (light blue) or ISRIB (dark blue) or young animals treated with vehicle (orange) showing the response to a current injection eliciting ~50 Hz spiking activity. Spikes are truncated (dashed line), and the AHP is visualized immediately following cessation of current injection (yellow square) and quantified as the change in voltage from baseline (dotted line). (B) Age-induced increases in AHP were measured when comparing young and old animals. ISRIB treatment reversed increased AHP to levels indistinguishable from young animals. Animals were injected with ISRIB (2.5 mg/kg) or vehicle intraperitoneal 1 day prior to recordings. One-way ANOVA (F = 4.461, p<0.05); with Tukey post-hoc analysis. *p<0.05. Each neuron is represented with a symbol; lines indicate the mean +- SEM (Neurons: Young males n = 10 (5 animals); Old males n = 12 (5 animals), Old + ISRIB males n = 19 (7 animals)) with 1-5 neurons recorded per animal. (C-E) Spine density was quantified in the CA1 region of the dorsal hippocampus from young and old Thy1-YFP-H mice. (C) Diagram of hippocampal region analyzed. SR = stratum radiatum. (D) Representative images from Old and Old + ISRIB mice. (E) A decrease in dendritic spine density was measured when comparing old mice to young mice. ISRIB treatment significantly increased spine density levels of old mice when compared to vehicle-treated old mice. 63x magnification with a water immersion objective. Young males n = 7 slides (two animals); Old males + Vehicle n = 12 slides (three mice); Old males + ISRIB n = 17 slides (four mice). Individual slide scores (relative to old mice) represented in dots, lines depict group mean +- SEM. One-way ANOVA (F = 18.57, p<0.001) with Tukey post-hoc analysis. **p<0.01; ***p<0.001. Figure 3--figure supplement 1. Figure 3--figure supplement 1.. Age and ISRIB... Figure 3--figure supplement 1.. Age and ISRIB treatment do not modify other passive or active... Figure 3--figure supplement 1.. Age and ISRIB treatment do not modify other passive or active intrinsic membrane properties in CA1 pyramidal neurons. (A) Representative traces from CA1 pyramidal neurons showing the membrane potential response to a 250 pA current injection in neurons from old animals treated with either vehicle (light blue) or ISRIB (dark blue) or young animals treated with vehicle (orange). Quantification of the action potential (AP) including the half width (B), amplitude (C), and threshold (D) did not show significant differences between CA1 pyramidal recordings from old, old + ISRIB-treated, or young mice. Likewise, evaluation of the maximum firing frequency (E) or how the frequency of spiking changes over time, quantified by the adaptation index (F) or with current injection, quantified by the slope of the relationship of firing frequency versus amplitude of current injection (F/I slope) (G) was also not significantly different between groups. Finally, passive membrane properties including the membrane time constant (tau) (H), membrane resistance (Rm) (I), and the resting membrane potential (J) were not significantly altered by age or ISRIB treatment. Each neuron is represented with a symbol; solid lines indicate the mean +- SEM. (One-way ANOVA for all comparisons; Neurons: and Young males n = 12 (5 animals); Old males n = 15 (5 animals), Old + ISRIB males n = 22 (7 animals)) with 1-5 neurons recorded per animal. Figure 3--figure supplement 2. Figure 3--figure supplement 2.. Age and ISRIB... Figure 3--figure supplement 2.. Age and ISRIB treatment do not affect spontaneous excitatory post-synaptic currents... Figure 3--figure supplement 2.. Age and ISRIB treatment do not affect spontaneous excitatory post-synaptic currents (sEPSC) in CA1 pyramidal neurons. (A) Representative whole cell voltage-clamp recordings showing sEPSCs from CA1 pyramidal neurons from old animals treated with either vehicle (light blue) or ISRIB (dark blue) or young animals treated with vehicle (orange). Arrows denote synaptic currents. (B) The sEPSC amplitude was not significantly different between groups (one-way ANOVA). (C) The sEPSC frequency was unchanged after ISRIB treatment or compared to young mice (Kruskal-Wallis test). The median amplitude or frequency for each neuron is represented with a symbol; solid lines indicate the mean +- SEM. (Neurons: Young males n = 11 (5 animals); Old males n = 15 (5 animals), Old + ISRIB males n = 18 (7 animals) with 1-5 neurons recorded per animal.). Figure 4. Figure 4.. Age-induced inflammatory tone is reduced... Figure 4.. Age-induced inflammatory tone is reduced following ISRIB treatment. Inflammatory genes were investigated in... Figure 4.. Age-induced inflammatory tone is reduced following ISRIB treatment. Inflammatory genes were investigated in the hippocampus of young and old mice by qPCR analysis. (A-C) ISRIB administration reversed age-induced increases in Rtp4, Ifit1, and Gbp10. (A) Rtp4, One-way ANOVA (F = 12.23, p<0.001) with a Tukey-post analysis. Young males n = 8; Old males n = 7; Old + ISRIB males n = 8. (B) Ifit1, One-way ANOVA (F = 8.8; p<0.01) with a Tukey-post analysis. Young males n = 8; Old males n = 7; Old + ISRIB males n = 8. (C) Gbp10, One-way ANOVA (F = F4.2, p<0.05) with a Tukey-post analysis. Young males n = 8; Old males n = 7; Old + ISRIB males n = 7. (D) Cd3 gene-expression (a marker for T cells) changes in the hippocampus of young and old animals were measured by qPCR analysis. Cd3 was significantly increased with age. ISRIB administration returned Cd3 expression levels to those comparable to young animals. One-way ANOVA (F = 5.2; p<0.05). Tukey-post hoc analysis. Young males n = 8; Old males n = 7; Old + ISRIB males n = 8. (E, F) Peripheral T cell levels were measured by flow cytometric analysis of whole blood. (E) ISRIB treatment reduced CD8^+ T cell percentages (of CD45^+ cells) in the peripheral blood. Student t-test. Old males n = 7; Old + ISRIB males n = 8. (F) CD4^+ T cell percentages (of CD45^+ cells) were not impacted. Individual animal scores represented by dots; lines depict group mean +- SEM. (G) A significant positive correlation was measured between cognitive performance on day 2 of the RAWM (errors) and multiple inflammatory markers (Cd3, Ifit1, Rtp4, Gbp10, Gbp5, Oasl1, Ccl2, Il-6). Linear regression was measured by Pearson R correlation, R value denoted with significance. *p<0.05; **p<0.01; ***p<0.001. Figure 4--figure supplement 1. Figure 4--figure supplement 1.. ISRIB administration does... Figure 4--figure supplement 1.. ISRIB administration does not impact glial cell activation. ( A )... Figure 4--figure supplement 1.. ISRIB administration does not impact glial cell activation. (A) ISRIB administration scheme. (B-G) Glial cell was quantified in the stratum radiatum of the CA1 region of the dorsal hippocampus from old Thy1-YFP-H mice. GFAP was used to measure astrocyte activity. Representative images for GFAP staining of (B) old and (C) old + ISRIB mouse. (D) No differences in GFAP percent area were measured when comparing old and old + ISRIB animals. Iba-1 was used to measure microglia activity. Representative images for Iba-1 staining of (E) old and (F) old + ISRIB mouse. (G) No differences in Iba-1 percent area were measured when comparing old and old + ISRIB animals. 63x magnification with a water immersion objective. Old males n = 12-19 slides (three mice); Old males + ISRIB n = 18-20 slides (four mice). Individual slide scores (relative to old mice) represented in dots, lines depict group mean +- SEM. Figure 5. Figure 5.. ISRIB treatment resets age-related ISR... Figure 5.. ISRIB treatment resets age-related ISR activation. ( A ) A significant negative correlation... Figure 5.. ISRIB treatment resets age-related ISR activation. (A) A significant negative correlation was measured between cognitive performance on day 2 of the RAWM (errors) and Ppp1r15a mRNA expression. Linear regression was measured by Pearson R correlation, R value denoted with significance. (B) ISRIB treatment reduced p-eIF2a protein levels. Brain lysates of p-eIF2a protein levels normalized to actin. Old males n = 10; ISRIB males n = 10. Student's t-test. **p<0.01. Data are means +- SEM. Figure 5--figure supplement 1. Figure 5--figure supplement 1.. ISRIB treatment breaks... Figure 5--figure supplement 1.. ISRIB treatment breaks age-related ISR activation. The impact of ISRIB on... Figure 5--figure supplement 1.. ISRIB treatment breaks age-related ISR activation. The impact of ISRIB on p-eIF2 was investigated by western blot analysis of brain lysates after three ISRIB injections. Raw western blot data. Each lane represents an individual animal brain extract. All figures (13) See this image and copyright information in PMC Similar articles * Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury. Chou A, Krukowski K, Jopson T, Zhu PJ, Costa-Mattioli M, Walter P, Rosi S. Chou A, et al. Proc Natl Acad Sci U S A. 2017 Aug 1; 114(31):E6420-E6426. doi: 10.1073/pnas.1707661114. Epub 2017 Jul 10. Proc Natl Acad Sci U S A. 2017. PMID: 28696288 Free PMC article. * Small molecule ISRIB suppresses the integrated stress response within a defined window of activation. Rabouw HH, Langereis MA, Anand AA, Visser LJ, de Groot RJ, Walter P, van Kuppeveld FJM. Rabouw HH, et al. Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2097-2102. doi: 10.1073/pnas.1815767116. Epub 2019 Jan 23. Proc Natl Acad Sci U S A. 2019. PMID: 30674674 Free PMC article. * Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule. Tsai JC, Miller-Vedam LE, Anand AA, Jaishankar P, Nguyen HC, Renslo AR, Frost A, Walter P. Tsai JC, et al. Science. 2018 Mar 30;359(6383):eaaq0939. doi: 10.1126/science.aaq0939. Science. 2018. PMID: 29599213 Free PMC article. * Structural insights into ISRIB, a memory-enhancing inhibitor of the integrated stress response. Anand AA, Walter P. Anand AA, et al. FEBS J. 2020 Jan;287 (2):239-245. doi: 10.1111/febs.15073. Epub 2019 Nov 7. FEBS J. 2020. PMID: 31550413 Review. * The integrated stress response: From mechanism to disease. Costa-Mattioli M, Walter P. Costa-Mattioli M, et al. Science. 2020 Apr 24;368(6489):eaat5314. doi: 10.1126/science.aat5314. Science. 2020. PMID: 32327570 Free PMC article. Review. See all similar articles Cited by * The landscape of aging. Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, Zhang X, Zhang W, Liu B, An Y, Li J, Tang B, Pei S, Wu X, Liu Y, Zhuang CL, Ying Y, Dou X, Chen Y, Xiao FH, Li D, Yang R, Zhao Y, Wang Y, Wang L, Li Y, Ma S, Wang S, Song X, Ren J, Zhang L, Wang J, Zhang W, Xie Z, Qu J, Wang J, Xiao Y, Tian Y, Wang G, Hu P, Ye J, Sun Y, Mao Z, Kong QP, Liu Q, Zou W, Tian XL, Xiao ZX, Liu Y, Liu JP, Song M, Han JJ, Liu GH. Cai Y, et al. Sci China Life Sci. 2022 Sep 2:1-101. doi: 10.1007/s11427-022-2161-3. Online ahead of print. Sci China Life Sci. 2022. PMID: 36066811 Free PMC article. Review. * Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activities. Lu Z, Bae EA, Verginadis II, Zhang H, Cho C, McBrearty N, George SS, Diehl JA, Koumenis C, Bradley LM, Fuchs SY. Lu Z, et al. Cancer Immunol Immunother. 2022 Sep 5. doi: 10.1007/ s00262-022-03286-2. Online ahead of print. Cancer Immunol Immunother. 2022. PMID: 36063172 * Keeping synapses in shape: degradation pathways in the healthy and aging brain. Kuijpers M. Kuijpers M. Neuronal Signal. 2022 Jun 15;6 (2):NS20210063. doi: 10.1042/NS20210063. eCollection 2022 Jun. Neuronal Signal. 2022. PMID: 35813265 Free PMC article. Review. * Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration. Jhanji M, Rao CN, Massey JC, Hope MC 3rd, Zhou X, Keene CD, Ma T, Wyatt MD, Stewart JA, Sajish M. Jhanji M, et al. Nat Commun. 2022 Jun 10;13(1):3244. doi: 10.1038/s41467-022-30785-8. Nat Commun. 2022. PMID: 35688816 Free PMC article. * Regulation and function of elF2B in neurological and metabolic disorders. Hanson FM, Hodgson RE, de Oliveira MIR, Allen KE, Campbell SG. Hanson FM, et al. Biosci Rep. 2022 Jun 30;42(6):BSR20211699. doi: 10.1042/BSR20211699. Biosci Rep. 2022. PMID: 35579296 Free PMC article. Review. See all "Cited by" articles References 1. 1. Aging C. Progress in Understanding and Opportunities for Action. Washington: National Academies Press; 2015. - DOI - PubMed 2. 1. Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nature Protocols. 2006;1:1671-1679. doi: 10.1038/nprot.2006.275. - DOI - PubMed 3. 1. An Aging Nation . The Older Population in the United States. United States Census Bureau; 2014. https://www.census.gov/ library/publications/2014/demo/p25-1140.html 4. 1. Anderson ND, Craik FI, Naveh-Benjamin M. The attentional demands of encoding and retrieval in younger and older adults: 1 evidence from divided attention costs. Psychology and Aging. 1998;13:405-423. doi: 10.1037/0882-7974.13.3.405. - DOI - PubMed 5. 1. Azzu V, Valencak TG. Energy metabolism and ageing in the mouse: a Mini-Review. Gerontology. 2017;63:327-336. doi: 10.1159/000454924. - DOI - PubMed Show all 73 references Publication types * Research Support, N.I.H., Extramural Actions + Search in PubMed + Search in MeSH + Add to Search * Research Support, Non-U.S. Gov't Actions + Search in PubMed + Search in MeSH + Add to Search MeSH terms * Acetamides / pharmacology* Actions + Search in PubMed + Search in MeSH + Add to Search * Activating Transcription Factor 4 / metabolism Actions + Search in PubMed + Search in MeSH + Add to Search * Aging / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Animals Actions + Search in PubMed + Search in MeSH + Add to Search * Brain / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Cognitive Dysfunction / drug therapy Actions + Search in PubMed + Search in MeSH + Add to Search * Cyclohexylamines / pharmacology* Actions + Search in PubMed + Search in MeSH + Add to Search * Dendritic Spines / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Female Actions + Search in PubMed + Search in MeSH + Add to Search * Hippocampus / cytology Actions + Search in PubMed + Search in MeSH + Add to Search * Hippocampus / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Male Actions + Search in PubMed + Search in MeSH + Add to Search * Memory / drug effects* Actions + Search in PubMed + Search in MeSH + Add to Search * Mice Actions + Search in PubMed + Search in MeSH + Add to Search * Mice, Inbred C57BL Actions + Search in PubMed + Search in MeSH + Add to Search * Neurons / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Nootropic Agents / pharmacology* Actions + Search in PubMed + Search in MeSH + Add to Search * Spatial Learning / drug effects Actions + Search in PubMed + Search in MeSH + Add to Search * Stress, Physiological Actions + Search in PubMed + Search in MeSH + Add to Search Substances * 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido) cyclohexyl)acetamide Actions + Search in PubMed + Search in MeSH + Add to Search * Acetamides Actions + Search in PubMed + Search in MeSH + Add to Search * Atf4 protein, mouse Actions + Search in PubMed + Search in MeSH + Add to Search * Cyclohexylamines Actions + Search in PubMed + Search in MeSH + Add to Search * Nootropic Agents Actions + Search in PubMed + Search in MeSH + Add to Search * Activating Transcription Factor 4 Actions + Search in PubMed + Search in MeSH + Add to Search Related information * MedGen * PubChem Compound (MeSH Keyword) Grant support * R01 AG056770/AG/NIA NIH HHS/United States * TL1 TR001871/TR/NCATS NIH HHS/United States * AFB 170004/Programa de Apoyo a Centros con Financiamiento Basal/ International * R25 GM056847/GM/NIGMS NIH HHS/United States * F32 AG054126/AG/NIA NIH HHS/United States * K08 NS114170/NS/NINDS NIH HHS/United States Show all 6 grants LinkOut - more resources * Full Text Sources + Europe PubMed Central + PubMed Central + eLife Sciences Publications, Ltd * Other Literature Sources + Bio-101 Improve Research Reproducibility + Faculty Opinions * Medical + MedlinePlus Health Information Full text links [x] full text provider logo eLife Sciences Publications, Ltd Free PMC article [x] Cite Copy Download .nbib Format: [NLM] Send To * Clipboard * Email * Save * My Bibliography * Collections * Citation Manager [x] NCBI Literature Resources MeSH PMC Bookshelf Disclaimer Follow NCBI Connect with NLM * * * National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894 Web Policies FOIA HHS Vulnerability Disclosure Help Accessibility Careers * NLM * NIH * HHS * USA.gov